Dual PPAR Agonist Action Saroglitazar activates both PPAR-α and PPAR-γ receptors, improving lipid metabolism and insulin sensitivity to help manage diabetic dyslipidemia effectively.
Comprehensive Lipid Control Significantly reduces triglycerides and LDL cholesterol while moderately increasing HDL cholesterol—helpful in patients with type 2 diabetes and elevated lipid levels.
Metabolic Benefits Lowers blood sugar and improves insulin resistance, offering added benefits beyond lipid control for diabetic patients.
Once-Daily Oral Dose Designed for convenience and adherence with a single tablet taken daily, often alongside standard diabetic treatments like metformin or statins.
Find products similar to Bilypsa Saroglitazar Tablets
Interested in this product?Get Latest Price from the seller
About the Company
GST Registration Date
20-04-2024
Legal Status of Firm
Proprietorship
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
0 - 40 L
IndiaMART Member Since
Jan 2015
GST
07GRLPK2558F1ZI
Established in the year 2024, Divyam Pharmaceuticals has quickly emerged as a trusted name in the pharmaceutical industry. We are a leading Wholesaler, Retailer, and Service Provider of a wide range of high-quality pharmaceutical products, including Pharmaceutical Tablets, Pharmaceutical Injections, Pharmaceutical Capsules, Pharmaceutical Third Party Manufacturing Services.
At Divyam Pharmaceuticals, we are committed to delivering effective and affordable healthcare solutions. Our mission is to ensure the availability of safe, reliable, and result-oriented medicines to our clients and healthcare partners. We work with certified manufacturers and follow strict quality control processes to meet industry standards.
With a customer-centric approach, timely delivery, and transparent business practices, we strive to build long-term relationships in the healthcare sector.
